Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder

Table 8

The distribution of toxocariasis according to the age in patients with schizophrenia disorder and healthy controls.

	Patients’ group	Healthy	Sig	OR	CI95
	𝑁 (%)	𝑁 (%)
Age (years)
<20	0 (0%)	0 (0%)
20–29	4/32 (12.5%)	3/83 (4.81%)	0.1	2.9	0.68–12.5
30–39	6/34 (17.14%)	1/7 (14.28%)	0.6	1.2	0.12–12.2
40–49	2/23 (8.69%)	0/0 (0%)
>50	2/11 (18.18%)	0/1 (0%)	0.8	0.81	0.61–1.08